I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 24% ± 9% | |
| natural killer cell | 7 studies | 22% ± 7% | |
| epithelial cell | 6 studies | 41% ± 17% | |
| CD8-positive, alpha-beta T cell | 6 studies | 19% ± 2% | |
| fibroblast | 5 studies | 22% ± 5% | |
| regulatory T cell | 5 studies | 18% ± 2% | |
| conventional dendritic cell | 4 studies | 24% ± 10% | |
| non-classical monocyte | 4 studies | 21% ± 5% | |
| connective tissue cell | 4 studies | 19% ± 3% | |
| pericyte | 4 studies | 19% ± 4% | |
| macrophage | 4 studies | 26% ± 11% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 3% | |
| classical monocyte | 3 studies | 24% ± 3% | |
| hematopoietic precursor cell | 3 studies | 27% ± 6% | |
| smooth muscle cell | 3 studies | 16% ± 0% | |
| B cell | 3 studies | 21% ± 3% | |
| myeloid cell | 3 studies | 25% ± 6% | |
| ciliated cell | 3 studies | 33% ± 4% | |
| erythroblast | 3 studies | 33% ± 18% | |
| goblet cell | 3 studies | 26% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 4% |
